Laboratorios Farmaceuticos Rovi, S.A. (BME:ROVI)
Spain · Delayed Price · Currency is EUR 72.20
+2.15 (3.07%)
At close: Jan 16, 2026
BME:ROVI Market Cap
BME:ROVI has a market cap or net worth of €3.69 billion as of January 16, 2026. Its market cap has increased by 12.02% in one year.
Market Cap
3.69B
Enterprise Value
3.78B
Revenue
724.20M
Ranking
n/a
PE Ratio
30.48
Stock Price
€72.20
Market Cap Chart
Since December 18, 2007, BME:ROVI's market cap has increased from 147.07M to 3.69B, an increase of 2,411.13%. That is a compound annual growth rate of 19.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 3.69B | 13.70% |
| Dec 31, 2025 | 3.25B | 0.87% |
| Dec 31, 2024 | 3.22B | 0.22% |
| Dec 29, 2023 | 3.21B | 66.93% |
| Dec 30, 2022 | 1.92B | -53.49% |
| Dec 30, 2021 | 4.14B | 97.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.76B |
| Almirall | 2.83B |
| Faes Farma | 1.59B |
| Pharma Mar | 1.39B |
| Clínica Baviera | 823.02M |
| Oryzon Genomics | 253.12M |
| Atrys Health | 227.62M |
| Prim, S.A. | 226.31M |